145 results
Page 6 of 8
8-K
EX-99.1
tzwzgqa
7 Nov 18
Zafgen Reports Third Quarter 2018 Operating and Financial Results
4:15pm
8-K
EX-99.1
sg5ie4fy 1u3d
7 Aug 18
Zafgen Reports Second Quarter 2018 Operating and Financial Results
4:21pm
8-K
EX-1.1
mypl dq94h61bi
28 Jun 18
Zafgen Announces Proposed Offering of Common Stock
5:01pm
424B5
528lj59t rec
28 Jun 18
Prospectus supplement for primary offering
4:54pm
424B5
vjji uu1ijz
27 Jun 18
Prospectus supplement for primary offering
4:49pm
8-K
EX-99.2
3s88e35s9irfjvnb9
25 Jun 18
Zafgen Announces Positive Full Results in Phase 2Proof-of-Concept Trial ofZGN-1061 in Patients withDifficult-to-Control Type 2 Diabetes
7:15am
8-K
EX-99.1
f187ix0z4 050
25 Jun 18
Zafgen Announces Positive Full Results in Phase 2Proof-of-Concept Trial ofZGN-1061 in Patients withDifficult-to-Control Type 2 Diabetes
7:15am
8-K
EX-99.1
vz1352w
8 May 18
Zafgen Reports First Quarter 2018 Operating and Financial Results
4:09pm